By expenditures
| Name | Title | Type |
|---|---|---|
| Clare Mundy | Chief Financial Officer | Auditee |
| John Armbrust | EXECUTIVE DIRECTOR AND FOUNDER | Auditee |
| Brian Razloznik | Partner | Auditee |
| Erica Stafford | PARTNER | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 332402 | 2024 | 2024-12-13 | Sutton Frost Cary LLP | $7.59M |
| 289861 | 2023 | 2024-02-12 | Blazek & Vetterling | $11.27M |
| 37810 | 2022 | 2022-12-12 | Blazek & Vetterling | $9.42M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 332402 | 2024 | 2024-12-13 | 1090642 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 1090641 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 1090640 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 1090639 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 1090638 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 1090637 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 1090636 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514200 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514199 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514198 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514197 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514196 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514195 | 2024-002 | Significant Deficiency | - | B |
| 332402 | 2024 | 2024-12-13 | 514194 | 2024-002 | Significant Deficiency | - | B |
| 289861 | 2023 | 2024-02-12 | 943259 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 943258 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 943257 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 943256 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 943255 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 943254 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 366817 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 366816 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 366815 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 366814 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 366813 | 2023-002 | Significant Deficiency | - | I |
| 289861 | 2023 | 2024-02-12 | 366812 | 2023-002 | Significant Deficiency | - | I |